source
- STAT+: Capsida says it still doesn’t know what caused gene therapy deathSome in the gene therapy field lament lost time while Capsida kept silent about the brain receptor it was targeting when things went wrong.STAT · 3mo ago↗ source
- A year after Vertex’s big launch, pain drug research faces a pivotal momentJournavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?BioPharma Dive · 3mo ago↗ source
- STAT+: In the battle of sepsis algorithms, performance alone doesn’t predict victoryAs new AI models for predicting sepsis hit the market, experts say performance alone will not drive adoption by hospitals.STAT · 3mo ago↗ source